Man­u­fac­tur­ing roundup: Bio­con ac­quires New Jer­sey man­u­fac­tur­ing site for $7M+; Ghana­ian man­u­fac­tur­er to fill-fin­ish cholera vac­cine

Bio­con Gener­ics, a sub­sidiary of In­dia-based man­u­fac­tur­er Bio­con, has ac­quired an oral med­i­cine pro­duc­tion fa­cil­i­ty in Cran­bury, NJ, from gener­ic man­u­fac­tur­er Ey­wa Phar­ma for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER